Not exact matches
Comparing a new patient's information with millions of other cases, Patient Rescue might be able to predict that they are in the
early stages of a
disease that has not yet become symptomatic, for example.
«Although there is a high risk of progression to decompensated cirrhosis and liver cancer among patients with advanced fibrosis, limiting access to people who have already progressed to late -
stage disease as
compared to treating
earlier to prevent these liver - related complications seems counter-intuitive as a public health strategy.»
Most excitingly, by
comparing between individual cells, the team expect to reveal differences which could play key roles in both the
early stages of life and the first
stages of
diseases such as cancer.
«Much to our surprise, the trial showed that patients receiving standard therapy
compared to those receiving cetuximab with standard therapy had no difference in outcomes,» said study author Dr. Steven Alberts, a professor of oncology at the Mayo Clinic College of Medicine in Rochester, Minn. «It also indicates that
disease in
earlier stages may be different than
diseases in later
stages.»